These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 1367062)
21. Screening of transformed insect cell lines for recombinant protein production. Keith MB; Farrell PJ; Iatrou K; Behie LA Biotechnol Prog; 1999; 15(6):1046-52. PubMed ID: 10585188 [TBL] [Abstract][Full Text] [Related]
22. Optimum infection conditions for recombinant protein production in insect cell (Bm5) suspension culture. Zhang J; Kalogerakis N; Behie LA; Iatrou K Biotechnol Prog; 1994; 10(6):636-43. PubMed ID: 7765698 [TBL] [Abstract][Full Text] [Related]
23. Technological progresses in monoclonal antibody production systems. Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321 [TBL] [Abstract][Full Text] [Related]
24. Systems biotechnology of mammalian cell factories. O'Callaghan PM; James DC Brief Funct Genomic Proteomic; 2008 Mar; 7(2):95-110. PubMed ID: 18326543 [TBL] [Abstract][Full Text] [Related]
25. Culture media for propagation of mammalian cells, viruses, and other biologicals. Jayme DW; Blackman KE Adv Biotechnol Processes; 1985; 5():1-30. PubMed ID: 2417609 [TBL] [Abstract][Full Text] [Related]
26. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387 [TBL] [Abstract][Full Text] [Related]
27. Manufacturing of recombinant therapeutic proteins in microbial systems. Graumann K; Premstaller A Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246 [TBL] [Abstract][Full Text] [Related]
28. In pursuit of the optimal fed-batch process for monoclonal antibody production. Bibila TA; Robinson DK Biotechnol Prog; 1995; 11(1):1-13. PubMed ID: 7765983 [TBL] [Abstract][Full Text] [Related]
29. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality. Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762 [TBL] [Abstract][Full Text] [Related]
30. Production of human alkaline phosphatase, a secreted, glycosylated protein, from a baculovirus expression system and the attachment-dependent cell line Trichoplusia ni BTI-Tn 5B1-4 using a split-flow, air-lift bioreactor. Chung IS; Taticek RA; Shuler ML Biotechnol Prog; 1993; 9(6):675-8. PubMed ID: 7764358 [TBL] [Abstract][Full Text] [Related]
31. Optimization of tetracycline-responsive recombinant protein production and effect on cell growth and ER stress in mammalian cells. Jones J; Nivitchanyong T; Giblin C; Ciccarone V; Judd D; Gorfien S; Krag SS; Betenbaugh MJ Biotechnol Bioeng; 2005 Sep; 91(6):722-32. PubMed ID: 15981277 [TBL] [Abstract][Full Text] [Related]
32. Impact of cell culture process changes on endogenous retrovirus expression. Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857 [TBL] [Abstract][Full Text] [Related]
34. Development of cell-free protein synthesis platforms for disulfide bonded proteins. Goerke AR; Swartz JR Biotechnol Bioeng; 2008 Feb; 99(2):351-67. PubMed ID: 17626291 [TBL] [Abstract][Full Text] [Related]
35. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells. Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959 [TBL] [Abstract][Full Text] [Related]